Western blot results in tumor tissues showed that erastin can increase the expression of SOCS2, but inhibit SLC7A11 and GPX4 expression, which can be further promoted by POU6F1 or lncRNA-CASC2 overexpression (Fig. 8D). The gene discussed is SLC7A11; the disease is neoplasm.